Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Verona Pharma plc buy Piper Sandler

Start price
€0.51
23.06.25 / 50%
Target price
€139.15
23.06.26
Performance (%)
-
End price
-
24.06.26
Summary
This prediction was cancelled by the user.
Performance without dividends (%)
Name 1w 1m 1y
Verona Pharma plc - - -
iShares Core DAX® -0,32 % -0,46 % 3,58 %
iShares Nasdaq 100 -0,38 % 1,36 % 35,01 %
iShares Nikkei 225® -0,91 % 9,39 % 62,39 %
iShares S&P 500 0,44 % 0,81 % 24,78 %

Comments by Piper_Sandler for this prediction

In the thread Verona Pharma plc diskutieren
Prediction Buy
Perf. (%) -
Target price 139.152
Change
Ends at 23.06.26

Verona Pharma PLC American Depositary Share (NASDAQ: VRNA) had its price target raised by analysts at Piper Sandler from $76.00 to $160.00. They now have an "overweight" rating on the stock.
Ratings data for VRNA provided by MarketBeat

In the thread Trading Verona Pharma plc
Prediction Buy
Perf. (%) -
Target price 139.152
Change
Ends at 23.06.26

Die von Piper_Sandler gewählte maximale Laufzeit wurde überschritten